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SUMMARY
A recent reduction in the number of smoke-related tumours has been observed thanks to the diffusion of anti-tobacco campaigns carried 
out in the majority of developed countries. Nevertheless, as demonstrated by recent global epidemiologic studies, squamous cell carcinoma 
of the mobile tongue appears to be progressively increasing in incidence, particularly among young adults and especially in females. The 
driving mechanism responsible for such changes is still to be precisely defined. Several genetic studies have compared the mutational pat-
tern of tongue squamous cell carcinoma in young adults to that of more elderly patients, without identifying significant differences that may 
help in better characterising this subgroup of subjects. Tongue squamous cell carcinomas in young adults have been historically considered 
as particularly aggressive clinical entities, with a high risk of loco-regional relapse, survival rates inferior to those of the general head and 
neck cancer group and need for a more aggressive therapy. However, considering the most recent studies, prognostic results in this patient 
group are heterogeneous and it is not possible to confirm this tendency. Thus, it is not justified to embrace different therapeutic approaches 
according to patient age. Eventually, an additional element to consider when examining young subjects affected by tongue cancer is the 
possibility of genetic predisposition. Alterations affecting pathways involved in DNA repair, surveillance of genetic stability or regulation 
of cellular growth may determine an increased likelihood of developing head and neck cancers.
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RIASSUNTO 
Grazie alla diffusione delle campagne anti-fumo che sono state portate avanti dalla maggior parte delle nazioni sviluppate, negli ultimi anni 
è stata osservata una riduzione del numero dei tumori ad esso correlati. Ciononostante, come dimostrato da recenti studi epidemiologici 
mondiali, l’incidenza dei carcinomi squamosi della porzione mobile della lingua è progressivamente aumentata, in particolare nei giovani e 
specialmente nelle donne. Il meccanismo responsabile di questi cambiamenti epidemiologici non è ancora stato precisamente definito. Diversi 
studi genetici hanno confrontato il pattern mutazionale dei carcinomi squamocellulari dei giovani rispetto a quelli dei soggetti più anziani, 
senza identificare differenze significative che permettano una migliore caratterizzazione di questo sottogruppo di pazienti. Storicamente, il 
carcinoma squamocellulare nei giovani è stato considerato come un’entità clinica particolarmente aggressiva, con un rischio maggiore di re-
cidiva loco-regionale ed un tasso di sopravvivenza inferiore rispetto alla popolazione generale dei pazienti con carcinomi testa e collo, che ne-
cessiterebbe di trattamenti più aggressivi. Considerando i più recenti studi, i risultati prognostici di questo gruppo di pazienti sono eterogenei 
e non è possibile confermare tale tendenza. Non sembra quindi al momento giustificato un approccio terapeutico differenziato in base all’età 
del paziente. Un altro elemento da prendere infine in considerazione quando si valutano pazienti affetti da carcinoma della lingua in giovane 
età, è la possibile presenza di una predisposizione genetica. Mutazioni che interessano i sistemi di riparazione del DNA, la sorveglianza della 
stabilità genetica o la regolazione della crescita cellulare possono determinare un aumento della probabilità di sviluppare un carcinoma del 
distretto testa-collo in giovane età.
PAROLE CHIAVE: Carcinoma della lingua • Giovani • Epidemiologia • Prognosi • Approccio terapeutico
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Introduction
Head and neck tumours are typically characterised by a 
peak of incidence in the elderly and a strong correlation 
with chronic exposure to risk factors such as smoking 
and alcohol abuse  1. This is a consequence of the typi-
cal pattern of initiation and neoplastic progression which 
is encountered in these anatomical sites, characterised 
by an incremental accumulation of mutations leading, in 
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the long-run, to frank neoplastic transformation 2. In this 
sense, the adult-elderly age has a central role in allowing 
the accumulation of a sufficient rate of genetic alterations 
to promote carcinogenesis 3 4.
Nevertheless, around 5% of patients suffering from head 
and neck cancer are diagnosed before they reach the age 
of 45 years. The incidence in this subgroup appears to be 
consistently growing, a trend that is in contrast to what 
observed in the general population. This phenomenon 
seems to be mainly linked to an increase of oropharyn-
geal carcinomas (mainly human papilloma virus [HPV]-
related) and of the oral cavity (apparently not related to 
any known virus), paralleled by a reduction of laryngeal 
and hypopharyngeal tumours 5.
The aim of this review is to collect evidence published in 
the recent literature and pertinent to such an epidemiolog-
ical trend, with special emphasis on oral tongue squamous 
cell carcinoma (SCC) in the young population. Due to the 
remarkable heterogeneity of studies assessing the molecu-
lar, epidemiological and clinical characteristics of tongue 
SCC, a non-structured review on all evidence available to 
date will be presented for each of these aspects.
Epidemiology
In oral cavity SCCs, gender distribution is different ac-
cording to the age of onset taken into consideration: while 
in the elderly, males represent over 70% of cases, this per-
centage falls to 50-65% under 45 years of age. This dif-
ference has increased evidence when considering that the 
majority of non-smokers and non-drinkers young patients 
are females 6 7. These epidemiological features may thus 
represent the expression of aetiopathogenic differences 
distinguishing the young subgroup of patients from the 
elderly. 
Thanks to the diffusion of anti-tobacco campaigns car-
ried out in the majority of developed countries, it has been 
possible to observe a recent reduction in the number of 
smoke-related tumours. Nevertheless, oral cavity SCC, in 
particular of the mobile tongue, as well as those of the 
oropharynx, appear to have a progressively increasing in-
cidence  8. While in oropharyngeal carcinomas this may 
be explained by an increasing exposure to the HPV, in the 
oral cavity, a specific pathogenic role for viral infections 
has yet to be demonstrated 9-11. 
Tongue SCCs demonstrate an increasing incidence in the 
young population, as previously reported in the 1990s by 
a group of American authors  12-14. These data were fur-
ther confirmed by a global study specifically investigating 
tongue carcinomas and including a total of 22 tumour reg-
istries. This study highlighted a yearly increase ranging 
from 0.4% to 3.3% that was significantly higher in young 
patients (< 45 years) in 14 out of 22 registries  8. In this 
comprehensive analysis, the greatest increase observed in 
females, particular in the younger cohort, was found only 
in some registries, while in others a homogenous distribu-
tion or even a male preponderance was shown 2 6 9 10 14 15. 
In this context, it is however important to point out the 
difficulties in sorting out precise data for particular sub-
groups with homogenous clinical characteristics. Consid-
ering these recent epidemiological changes, some authors 
have hypothesised the involvement of a viral agent in the 
carcinogenetic process which may be known or yet to be 
defined, even though no specific viral genetic material has 
been consistently isolated in tongue SCCs of young pa-
tients 16 17. 
Peculiarities of tongue tumours  
in young adults
From a clinical standpoint, tongue SCCs in the un-
der-45 year-old group, particularly if non-smokers and 
non-drinkers, are found to prevalently originate from 
the tongue edge 16. The concept of “field cancerisation”, 
typically seen in the general head and neck cancer group, 
in these patients appears less evident, with a pattern of 
relapse/second tumour generally characterised by the in-
volvement of the residual tongue in continuity with the 
primary neoplastic lesion 16 18 19. However, no evidence of 
differences in histopathological features have been report-
ed 20. Some authors have also described the relapse ten-
dency in the first two years of follow-up, with a significant 
decrease in risk following this lapse of time 21. 
Considering the varied epidemiological characteristics, 
some genetic studies have compared the mutational pat-
tern of tongue SCCs in young adults to that of more el-
derly patients. In the vast majority of publications, the 
two types of tumours have been shown to be similar and 
generally comparable to head and neck carcinomas 22. The 
most frequently mutated genes have been reported to be 
TP53, CDKN2A, NOTCH1, CASP8, FAT1, PIK3CA and 
MLL2 in both groups of patients 23. In the literature, how-
ever, heterogeneous results have been reported in relation 
to the prevalence of p53 mutations in young patients, with 
a tendency to a significant increase in some studies 23 and 
a decrease in others, in particular for non-smokers 24 25. A 
recent analysis performed by Knopf and colleagues 26 has 
shed further light on the molecular mechanisms linked to 
the starting of tongue SCCs in patients below 45 years of 
age, highlighting a predominant alteration of the WNT-
CTNNB1-STK11 and CDKN2A-HGF-MET pathways, 
as well as increased expression of ATM, BRCA1, E2F1, 
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and FHIT. Such a biological molecular landscape may 
be associated with greater radio-sensitivity in this patient 
population, which has significant consequences from the 
therapeutic and prognostic points of view 27-30. 
However, these differences in genes mutation/expression 
may be mainly related to heterogeneous study popula-
tions: when analysing the extensive “The Cancer Genome 
Atlas” (TCGA) database, it is not possible to confirm any 
significant difference in relation to age, even considering 
the most recent genomic data 31 32. Thus, tongue SCC in 
young patients appears to be comparable to those in el-
derly patients even when taking into account their genetic 
alterations.
Prognosis
Historically, tongue SCCs in young adults have been 
considered by many authors as particularly aggressive 
clinical entities, with a high risk of loco-regional re-
lapse, and survival rates inferior to that of the general 
population and resulting need for a more aggressive 
course of therapy  12 33-35. However, considering the most 
recent studies, the prognostic results in this patient group 
are heterogeneous and it is not possible to confirm this ten-
dency 12 13 19 24 33 35-41. This heterogeneity of results may also 
depend on the variable definition of “young age”, with a 
wide range of cut-offs going from 30 to 45 years of age. In 
the future, to make the data more homogeneous and com-
parable, it has been suggested that it might be useful to con-
sider as young patients only those below the age of 30 42. 
In the specific field of tongue SCCs, the analysis of a wide 
case series of 276 patients (66 below and 210 over the age 
of 45) performed by Knopf and colleagues 26 has revealed 
a significant prognostic advantage in younger patients. 
Regardless of this consideration, it is crucial to interpret 
this result as likely influenced by tumour extension, and 
thus T category, which is significantly lower in patients 
below 45 years of age (without differences in N and M 
categories). This selection bias is partly mitigated by 
case-matched studies characterised by a homogenous pa-
tient distribution in relation to tumour characteristics and 
comorbidities. Considering these types of studies, a broad 
cohort of 185 patients below the age of 45 affected by 
head and neck SCC, 80 of which of the oral cavity, com-
pared with an analogous group of elderly subjects, dem-
onstrated better results in terms of overall survival and 
second tumour occurrence in young patients 13. Focusing 
the analysis on tongue carcinomas, 20 cases under-45 
years compared with the same number of older subjects, 
matched by stage and gender, highlighted better overall 
and disease-related survivals in the younger subgroup 43. 
On the other hand, some studies have demonstrated the ab-
sence of prognostically significant differences, taking into 
account 87 patients ≤ 45 years of age in a study by Lassig 
and colleagues 44 and 31 patients ≤ 40 years analysed by 
Pytynia and coworkers 45, both case-matched and includ-
ing head and neck tumours in general. Finally, Blanchard 
and co-authors 46 have recently confirmed the absence of 
significant differences in 50 patients ≤ 40 years affected 
by tongue carcinomas versus older subjects matched by 
stage at presentation. It is nevertheless important to point 
out the outlier results on tongue SCC reported by at least 
three different studies  47-49, which showed a significant 
increase of relapses in young adults and a related nega-
tive impact on overall survival within this cohort. A non-
significant trend towards poorer prognosis has also been 
reported by the group led by Kourelis 50 which considered 
only patients with early stage tongue SCCs. In particular, 
in young women, there has also been evidence of a signifi-
cant increase in the risk of relapse compared to matched 
cases 50. 
Genetically-determined conditions  
of increased susceptibility to tongue cancer
An additional element to take into consideration when ex-
amining patients affected by tongue SCC in the young age 
is the possibility of some sort of genetic predisposition 2. 
Alterations affecting pathways involved in DNA repair, 
surveillance of genetic stability or regulation of cellular 
growth may determine an increased likelihood of devel-
oping head and neck cancers. This is clearly exemplified 
in rare hereditable syndromes linked to specific genetic 
mutations leading to a dramatically increased incidence 
of head and neck cancers and tumours in general. These 
are represented, in particular, by Fanconi anaemia, xero-
derma pigmentosum, Bloom, Li-Fraumeni, familial atypi-
cal multiple mole melanoma, and ataxia telangiectasia 
syndromes. In all these diseases, the increased risk in de-
veloping tongue SCC (that may reach an incidence up to 
700-1000 greater than that for the general population) can 
be associated with that reported for other neoplasms and 
syndromic presentations. The suspicion of a genetically-
determined alteration should arise from a detailed family 
history of the proband positive for: 1) first-degree relative 
with the same kind of tumour and same clinical presenta-
tion; 2) two or more first-degree relatives with a tumour 
in the same location; 3) two or more first-degree relatives 
affected by rare tumours.
It is, however, important to note the existence of increased 
susceptibility to head and neck cancers even in the ab-
sence of syndromic presentations. Retrospective studies 
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have, in fact, demonstrated a relative risk that is increased 
3.6-fold in subjects with first-degree relatives affected by 
other head and neck cancers 51-53. In addition, young adults 
affected by tumours in these locations have been shown to 
be increasingly susceptible to genotoxic stress as shown 
by the bleomycin test, strongly suggesting the develop-
ment of an increased number of chromosomal altera-
tions in respect to older subjects 53. In a similar manner, 
young adults affected by such neoplasms have shown an 
increased vulnerability to the negative effects of smoking 
(compared to healthy volunteers), a feature likely linked 
to an increased prevalence in this population of single nu-
cleotide polymorphisms in genes involved in the repair of 
alcohol- and smoke-related mutations and in regulation of 
the cell cycle 54-56.
Conclusions
Tongue SCC in young adults represents a rare disease, 
characterised by an incidence that has been recently re-
ported as increasing, particularly in females. However, 
no specific aetiopathogenic agent has been identified to 
date that may provide a univocal explanation for such a 
trend. As of today, it is not possible to demonstrate signifi-
cant differences with respect to the general head and neck 
cancer patients group in terms of prognosis and, thus, a 
comprehensive therapeutic approach according to current 
guidelines should be recommended. In this view, thanks 
to the overall fitness of young patients, the “optimal treat-
ment” according to tumour stage and characteristics may 
be frequently obtained, while it is essential to avoid unjus-
tified overtreatments on the basis of patient’s age alone. 
In consideration of the patients’ life expectancy, function-
al impairment and risk of recurrence, a long-lasting fol-
low-up should be considered, with the aim of allowing an 
early diagnosis of persistent/recurrent disease, monitoring 
and optimising the patient’s quality of life, and promoting 
awareness of adjunctive risk factors such as tobacco or 
alcohol consumption.
Patients presenting with associated syndromic character-
istics, a suggestive family history and age of onset below 
20-30 years might also require detailed genetic counsel-
ling to better assess the general disease framework.
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